Juana María Cano

892 total citations
25 papers, 136 citations indexed

About

Juana María Cano is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Juana María Cano has authored 25 papers receiving a total of 136 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Juana María Cano's work include Colorectal Cancer Treatments and Studies (5 papers), Sarcoma Diagnosis and Treatment (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Juana María Cano is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Sarcoma Diagnosis and Treatment (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Juana María Cano collaborates with scholars based in Spain, Chile and Palestinian Territory. Juana María Cano's co-authors include Yolanda Rodríguez, Juan Luis Garcı́a, Rafael López‐López, Daniel Rueda, Miguel Urioste, José Perea, Rogelio González‐Sarmiento, Mariano García‐Arranz, Damián García‐Olmo and Lucía Inglada‐Pérez and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Juana María Cano

22 papers receiving 136 citations

Peers

Juana María Cano
Mariaelena Casagrande Italy
Audrey Lardy-Cléaud France
Sherif Raouf United Kingdom
Cristina Morelli Italy
Jamal Misleh United States
Regina Gironés Sarrió Spain
Adriana Rosé Argentina
Jean Marc Ferrero France
Shirley Mo United States
Roberto Díaz Beveridge Spain
Mariaelena Casagrande Italy
Juana María Cano
Citations per year, relative to Juana María Cano Juana María Cano (= 1×) peers Mariaelena Casagrande

Countries citing papers authored by Juana María Cano

Since Specialization
Citations

This map shows the geographic impact of Juana María Cano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juana María Cano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juana María Cano more than expected).

Fields of papers citing papers by Juana María Cano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juana María Cano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juana María Cano. The network helps show where Juana María Cano may publish in the future.

Co-authorship network of co-authors of Juana María Cano

This figure shows the co-authorship network connecting the top 25 collaborators of Juana María Cano. A scholar is included among the top collaborators of Juana María Cano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juana María Cano. Juana María Cano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carrillo, Jaime, Nadia Hindi, Gloria Marquina, et al.. (2024). Delays in diagnosis and surgery of sarcoma patients during the COVID-19 outbreak in Spain. Therapeutic Advances in Medical Oncology. 16. 2665347–2665347. 1 indexed citations
2.
Jiménez‐Fonseca, Paula, Juana María Cano, Virginia Arrazubi, et al.. (2023). State of the scientific evidence and recommendations for the management of older patients with gastric cancer. Journal of Geriatric Oncology. 15(3). 101657–101657. 2 indexed citations
3.
Capdevila, Jaume, Ismael Macías, Ignacio Escobar, et al.. (2023). Atezolizumab plus tiragolumab in combination with chemoradiotherapy in localized squamous cell carcinoma of the anal canal: TIRANUS (GEMCAD-2103) trial.. Journal of Clinical Oncology. 41(16_suppl). TPS3624–TPS3624.
4.
Montés, Ana Fernández, Javier Ros, Pilar García‐Alfonso, et al.. (2023). Effectiveness and safety of encorafenib-cetuximab in BRAFV600E metastatic colorectal cancer: Confidence study.. Journal of Clinical Oncology. 41(4_suppl). 126–126. 2 indexed citations
5.
Gil-Raga, Mireia, Paula Jiménez‐Fonseca, Ismael Ghanem, et al.. (2022). Uncertainty and hope in relation to anxiety and depression in advanced lung cancer. BMJ Supportive & Palliative Care. 13(e3). e847–e850. 8 indexed citations
6.
7.
Santaballa, Ana, et al.. (2020). SEOM clinical guideline for secondary prevention (2019). Clinical & Translational Oncology. 22(2). 187–192. 6 indexed citations
8.
Cano, Juana María, Juan Luis Garcı́a, Susana Olmedillas‐López, et al.. (2019). Clinical and Molecular Comparative Study of Colorectal Cancer Based on Age-of-Onset and Tumor Location: Two Main Criteria for Subclassifying Colorectal Cancer. International Journal of Molecular Sciences. 20(4). 968–968. 24 indexed citations
9.
10.
Hindi, Nadia, Rafael Ramos, Javier Martínez‐Trufero, et al.. (2018). Prognostic role of HMG proteins in a series of 301 advanced soft tissue sarcoma patients: A Spanish Group for Sarcoma Research Study (GEIS).. Journal of Clinical Oncology. 36(15_suppl). 11573–11573. 1 indexed citations
11.
Cano, Juana María, et al.. (2017). Recurrent Metastatic Medullary Thyroid Carcinoma: A Case of Sustained Response to Prolonged Treatment with Somatostatin Analogues. Thyroid. 27(11). 1450–1455. 10 indexed citations
12.
Carmona‐Bayonas, Alberto, Andrés J. Muñoz Martín, Luisa Sánchez‐Lorenzo, et al.. (2016). First-line triplet or doublet chemotherapy for advanced gastric cancer: Analysis of 970 patients from a community practice registry. Annals of Oncology. 27. vi212–vi212. 3 indexed citations
13.
García‐Alfonso, Pilar, Silvia Gil, Rosario Dueñas, et al.. (2015). Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents. Targeted Oncology. 10(4). 453–465. 15 indexed citations
14.
Pérez‐Segura, Pedro, Ray Manneh Kopp, Manuel Benavides, et al.. (2015). GEINOFOTE: efficacy and safety of fotemustine in patients with high-grade recurrent gliomas and poor performance status. Clinical & Translational Oncology. 18(8). 805–812. 8 indexed citations
15.
Perea, José, Juana María Cano, Daniel Rueda, et al.. (2015). Classifying early-onset colorectal cancer according to tumor location: new potential subcategories to explore.. PubMed. 5(7). 2308–13. 14 indexed citations
16.
Londoño, G.A. Jiménez, Ana María García Vicente, A. León Martín, et al.. (2014). 18 F-FDG PET/contrast enhanced CT in the standard surveillance of high risk colorectal cancer patients. European Journal of Radiology. 83(12). 2224–2230. 7 indexed citations
17.
Martínez‐Trufero, Javier, Rosa Álvarez, Isabel Sevilla, et al.. (2014). Multidisciplinary Treatment Outcome of Desmoid-Type Fibromatosis (Dtf). a Registry-Based Study from Spanish Group for Research on Sarcoma (Geis). Annals of Oncology. 25. iv507–iv507. 1 indexed citations
18.
Jurado, Josefina Cruz, María Ángeles Vaz Salgado, Rosa Álvarez, et al.. (2014). Solitary Fibrous Tumor (Sft): a Registry Program to Assess Frequency and Managemente in Our Country. a Spanish Group for Research on Sarcoma (Geis) Study. Annals of Oncology. 25. iv507–iv507.
19.
Balañá, Carmen, María Ángeles Vaz Salgado, M.J. Molina-Garrido, et al.. (2013). Should we continue temozolomide beyond six cycles in the adjuvant treatment of glioblastoma without an evidence of clinical benefit? A cost analysis based on prescribing patterns in Spain. Clinical & Translational Oncology. 16(3). 273–279. 12 indexed citations
20.
Cano, Juana María, et al.. (2013). PET/triphasic contrast enhanced CT: Optimized protocol for the assessment of colorectal liver metastases. Revista Española de Medicina Nuclear e Imagen Molecular. 32(5). 336–337. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariaelena Casagrande Breakdown of academic impact, for papers by Audrey Lardy-Cléaud Breakdown of academic impact, for papers by Sherif Raouf Breakdown of academic impact, for papers by Cristina Morelli Breakdown of academic impact, for papers by Jamal Misleh Breakdown of academic impact, for papers by Regina Gironés Sarrió Breakdown of academic impact, for papers by Adriana Rosé Breakdown of academic impact, for papers by Jean Marc Ferrero Breakdown of academic impact, for papers by Shirley Mo Breakdown of academic impact, for papers by Roberto Díaz Beveridge
Rankless by CCL
2026